UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 20, 2021
Accession Number:
0001193125-21-301199
Submission Type:
POS AM
CIK:
0001479615
Company Name:
Silence Therapeutics plc
File Number:
333-248203